Phase 2, dose-ranging study of vupanorsen in patients with diabetes, steatosis and hypertriglyceridaemia (NCT03371355)

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Amarin Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Pfizer Logo